Namur, Belgium

Alain Krief

This inventor holds 3 USPTO granted patents, plus 2 CIPO patents and 1 EPO patent. Top assignees: Janssen Pharmaceutica Nv, Janssen Pharmaceutica. Active years: 2006-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alain Krief. Retrieved from https://idiyas.com/inventor/alain-krief-w97pfc4p

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0



Average Co-Inventor Count = 10.3

ph-index = 2

Forward Citations = 33(Granted Patents)


Company Filing History:


Years Active: 2006-2010

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Alain Krief - Innovative Mind from Namur

Introduction: Alain Krief, a talented inventor hailing from Namur, Belgium, is known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Alain Krief holds several patents in the areas of renewable energy, sustainable transportation, and smart city solutions, showcasing his commitment to creating a more eco-friendly world.

Career Highlights: With a career spanning over two decades, Alain Krief has worked with leading research institutions and tech companies to develop cutting-edge technologies that have revolutionized various industries.

Collaborations: Throughout his career, Alain Krief has collaborated with top engineers, scientists, and designers to bring his innovative ideas to life, resulting in successful products and solutions that have garnered international acclaim.

Conclusion: Alain Krief's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and entrepreneurs, solidifying his legacy as a true pioneer in the world of technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…